← Back to Patent Explorer
EP0285057B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same

Assignee: Enzo Biochem Inc
•
Filing: 1983-06-22
•
Granted: 1995-03-01
•
Expires: 2003-06-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a protein to which a moiety capable of chelating an ion is directly or indirectly attached, said attachment being characterized in not interfering substantially with the ability of the moiety to chelate ions.

Inventors

  • 👤 Dean Engelhardt
  • 👤 Elazar Rabbani
  • 👤 Stanley Kline
  • 👤 Jannis G. Stavrianopoulos
  • 👤 Dollie Kirtikar

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-03 09:39
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; C07; C07B; C07B59/00; C07B59/008; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07K; C07K17/00; C07K17/02; C07K17/06; C12Q1/6804

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 16 words
A nucleotide to which is covalently attached a moiety that is capable of chelating an ion.
Claim 2
Dependent Claim 350 words
The nucleotide according to claim 1 selected from the group consisting of: (i) a nucleotide having the formula P-S-B-Sig wherein P is a phosphate moiety, S is a sugar moiety, B is a pyrimidine, purine or 7-deazapurine moiety, Sig comprises a moiety capable of chelating a detectable ion, P being attached at the 3' or the 5' position of S when the nucleotide is a deoxyribonucleotide and at the 2', 3' or 5' position when the nucleotide is a ribonucleotide, B being attached to the 1' position of S from the N¹ position when B is a pyrimidine or the N⁹ position when B is a purine or a 7-deazapurine, and Sig is directly or indirectly attached to B at a position other than the C⁵ position when B is a pyrimidine, at a position other than the C⁸ position when B is a purine and at a position other than the C⁷ position when B is a 7-deazapurine; (ii) a ribonucleotide having the formula, wherein P is a phosphate moiety, S is a sugar moiety, B is a pyrimidine purine or 7-deazapurine moiety, and Sig comprises a moiety capable of chelating a detectable ion, P being attached at the 2', 3' or 5' position of S, B being attached to the 1' position of S from the N¹ position when B is a pyrimidine or the N⁹ position when B is a purine or 7-deazapurine; and Sig is directly or indirectly attached to S; and (iii) a nucleotide having the formula, wherein P is a phosphate moiety, S is a sugar moiety, B is a pyrimidine, purine or 7-deazapurine moiety, Sig comprises a moiety capable of chelating a detectable ion, P being attached to the 3' or the 5' position of S when said nucleotide is a deoxyribonucleotide and at the 2', 3' or 5' position when said nucleotide is a ribonucleotide, B being attached to the 1' position of S from the N¹ position when B is a pyrimidine or the N⁹ position when B is a purine, and wherein Sig is directly or indirectly attached to P.
Claim 3
Dependent Claim 35 words
The nucleotide according to claim 2, wherein the moiety that is capable of chelating ions comprises two nitrogens and four carboxyl-containing groups, wherein two of said carboxyl-containing groups are attached to each of said nitrogens.
Claim 4
Dependent Claim 19 words
The nucleotide according to claim 3, wherein the moiety that is capable of chelating ions is a carboxy-substituted diamine.
Claim 5
Dependent Claim 27 words
The nucleotide according to claim 4, wherein the moiety that is capable of chelating ions has the structural formula: wherein M is hydrogen or a suitable cation.
Claim 6
Dependent Claim 27 words
The nucleotide according to claim 5, wherein the moiety that is capable of chelating ions has the structural formula: wherein M is hydrogen or a suitable cation.
Claim 7
Dependent Claim 27 words
The nucleotide according to claim 6, wherein the moiety that is capable of chelating ions has the structural formula: wherein M is hydrogen or a suitable cation.
Claim 8
Dependent Claim 54 words
The nucleotide according to claim 1, wherein the ion is selected from the group consisting of an ion of a radioactive metal, an ion of a metal capable of catalyzing a chromogenic or fluorogenic reaction and an ion of a metal capable of fluorescing or chemiluminescing alone or when in combination with another compound.
Claim 9
Dependent Claim 65 words
The nucleotide according to claim 1, wherein the moiety that is capable of chelating ions is covalently attached to the base, sugar or phosphorus-containing moiety through a linkage group, the linkage group including an olefinic bond at the α-position relative to the point of attachment to the nucleotide and/or including a -CH₂NH-moiety not interfering substantially with the characteristic ability of the moiety to chelate ions.
Claim 10
Dependent Claim 28 words
The nucleotide according to claim 1 further comprising a heavy metal or rare earth ion, the ion being chelated by the moiety that is capable of chelating ions.
Claim 11
Dependent Claim 14 words
The nucleotide according to claim 9, wherein the linkage group comprises an allylamine group.
Claim 12
Dependent Claim 10 words
The compound: wherein M is hydrogen or a suitable cation.
Claim 13
Dependent Claim 10 words
The compound: wherein M is hydrogen or a suitable cation.
Claim 14
Dependent Claim 30 words
An oligo- or polynucleotide characterized by at least one moiety that is capable of chelating ions, the moiety being attached to at least one nucleotide of the oligo- or polynucleotide.
Claim 15
Dependent Claim 38 words
The oligo- or polynucleotide according to claim 14, wherein said moiety that is capable of chelating ions comprises two nitrogens and four carboxyl-containing groups, wherein two of said four carboxyl-containing groups are attached to each of said nitrogens.
Claim 16
Dependent Claim 54 words
The nucleotide according to claim 10, wherein the ion is selected from the group consisting of an ion of a radioactive metal, an ion of a metal capable of catalyzing a chromogenic or fluorogenic reaction and an ion of a metal capable of fluorescing or chemiluminescing alone or when in combination with another compound.
Claim 17
Dependent Claim 21 words
The nucleotide according to claim 16, wherein the radioactive metal is an isotope of bismuth, nickel, tin, technetium, mercury or cobalt.
Claim 18
Dependent Claim 12 words
The nucleotide according to claim 16, wherein the catalyzing metal is cobalt.
Claim 19
Dependent Claim 30 words
The nucleotide according to claim 1, wherein the phosphorus-containing moiety is a mono-,di or tri-phosphate and the chemical moiety is covalently attached to the phosphorus-containing moiety through a phosphate oxygen.
Claim 20
Dependent Claim 13 words
The nucleotide according to claim 1 wherein said ion comprises a detectable ion.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag